SUMMARY  

• The company cannot support any practices, procedures, or storage conditions that deviate from product labeling. Please refer to local product labeling for information regarding storage and handling of BALVERSA.
• An in-use stability study of BALVERSA 3 mg, 4 mg, and 5 mg oral film-coated tablets was performed in high density polyethylene (HDPE) bottles with child resistant closure to simulate the daily use of the medication by the patient. The in-use stability study (short daily opening and closing of the original HDPE bottle) support stability of the product through 2 months of usage.¹